KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Gross Profit (2020 - 2025)

Historic Gross Profit for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $185.2 million.

  • Oscar Health's Gross Profit fell 4343.06% to $185.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year decrease of 881.17%. This contributed to the annual value of $1.7 billion for FY2025, which is 881.17% down from last year.
  • Per Oscar Health's latest filing, its Gross Profit stood at $185.2 million for Q4 2025, which was down 4343.06% from $399.7 million recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Gross Profit registered a high of $786.6 million during Q1 2025, and its lowest value of -$9.6 million during Q3 2021.
  • Its 5-year average for Gross Profit is $282.3 million, with a median of $257.5 million in 2022.
  • Examining YoY changes over the last 5 years, Oscar Health's Gross Profit showed a top increase of 250715.2% in 2021 and a maximum decrease of 15884.84% in 2021.
  • Quarter analysis of 5 years shows Oscar Health's Gross Profit stood at $13.6 million in 2021, then surged by 711.96% to $110.2 million in 2022, then soared by 105.42% to $226.4 million in 2023, then skyrocketed by 44.56% to $327.3 million in 2024, then crashed by 43.43% to $185.2 million in 2025.
  • Its last three reported values are $185.2 million in Q4 2025, $399.7 million for Q3 2025, and $311.0 million during Q2 2025.